U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research

U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research

English
3 Pages
Read
Download
Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Description

U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research PR Newswire ALBANY, New York, September 13, 2012 ALBANY, New York, September 13, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018", the U.S. vaccine market is estimated to be worth USD 12.8 billion in 2012 and is further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies about 80% of the U.S. vaccine market. Browse the database at http://www.transparencymarketresearch.com/us-vaccine-market.html U.S. will continue to lead the global vaccine market due to rising prevalence of infectious diseases in humans and animals, and advancement in biotechnology in the region. Short functional shelf life of certain vaccines will have negative impact on the market growth, but huge product pipeline of the multinational firms will overcome this concern and will drive the future growth of the market. Pediatric vaccine segment in the U.S. human vaccine market enjoys high share as well as high growth rate due to government compulsion for child immunization.

Subjects

Informations

Published by
Reads 14
Language English
Report a problem
U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research
PR Newswire ALBANY, New York, September 13, 2012
ALBANY, New York,September 13, 2012/PRNewswire/ --According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018", the U.S. vaccine market is estimated to be worthUSD 12.8 billionin 2012 and is further expected to reachUSD 17.4 billionby 2018, growing at a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies about 80% of the U.S. vaccine market. Browse the database at http://www.transparencymarketresearch.com/us-vaccine-market.html U.S. will continue to lead the global vaccine market due to rising prevalence of infectious diseases in humans and animals, and advancement in biotechnology in the region. Short functional shelf life of certain vaccines will have negative impact on the market growth, but huge product pipeline of the multinational firms will overcome this concern and will drive the future growth of the market. Pediatric vaccine segment in the U.S. human vaccine market enjoys high share as well as high growth rate due to government compulsion for child immunization. Adult & adolescent vaccine market is expected to grow moderately over the next six years due to rising awareness and increasing vaccination for human papillomavirus (HPV) and such other viral diseases.
Related & Recently Published Reports by Transparency Market Research
Minimally Invasive Surgery Market Weight Loss Market 2015 Global Osteoporosis Market Global Nutraceuticals Product Market Global Nutraceuticals Ingredients Market surgical equipment market size Asthma Drugs Industry Global Wound Dressing Industry Global Spectrometry Market Global Chromatography Market Livestock vaccine is the leading segment of the overall U.S. animal vaccine market accounting for 58.1% in 2012 due to more organized dairy sector and increased awareness towards prevention of infectious diseases in cattle. Bovine vaccine market is the largest revenue generating segment of the overall Livestock vaccine market in 2012 due to rising vaccination to protect breeding animals against infectious diseases. Together feline vaccine and canine vaccine
accounted for about 95.1% of the overall U.S. companion animal vaccine market in 2011. In 2011, overall leading producers of human vaccine for the U.S. market were Sanofi-Aventis, Merck, GlaxoSmithKline, Pfizer, Sanofi-Pasture and Novartis. The leading producers of animal vaccine for the U.S. market includes Pfizer Animal Health, Merial (Sanofi-Aventis), Intervet/Schering-Plough (Merck) and Novartis Animal Health. This report helps to identify factors, which will be the driving force behind the U.S. Vaccine market and sub-markets in the next six years. The report provides extensive analysis of the U.S. vaccine market, current market trends, industry drivers and challenges for better understanding of the U.S. vaccine market structure. The report has segregated the U.S. vaccine industry in terms of its product type. Annual estimates and forecasts are provided for the period 2012 through 2018 in terms of value in USD million.
Segments Analyzed
U.S. vaccine market- by Product
Human vaccine
Pediatric Vaccines Adult & Adolescent vaccine Other human vaccine
Animal vaccine
Livestock vaccine
Bovine vaccine Porcine vaccine Ovine vaccine
Companion animal vaccine
Feline vaccine Canine vaccine Equine vaccine
Other animal vaccine
Browse all PharmaceuticalMarketResearch Reports Upcoming Reports inPharmaceuticalMarket Cancer Biomarkers Market Health And Wellness Market Biotechnology Market Non Small Cell Lung Cancer Market Healthcare Equipment Market Genitourinary Drugs Market The Role of IT and Telecom in Healthcare Industry Medical Education Market Needle Free Delivery Devices Market Biomarkers Market About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Sheela AK 90 Sate Street, Suite 700 Albany, NY12207 Tel: +1-518-618-1030 USA- Canada Toll Free: 866-552-3453 Email:sales@transparencymarketresearch.com